These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Purification of triamcinolone acetonide suspension for intravitreal injection. Soto-Pedre E Br J Ophthalmol; 2006 Jan; 90(1):123-4. PubMed ID: 16361689 [No Abstract] [Full Text] [Related]
12. Triamcinolone acetonide concentration after filtration of the solvent agent. Spandau UH; Derse M; Schmitz-Valckenberg P; Papoulis C; Sagstetter BU; Stiefvater K; Jonas JB Am J Ophthalmol; 2005 Apr; 139(4):712-3. PubMed ID: 15808171 [TBL] [Abstract][Full Text] [Related]
13. Quantification of sedimented triamcinolone for intravitreal injection. Tsong JW; Persaud TO; Mansour SE Retina; 2007; 27(9):1255-9. PubMed ID: 18046234 [TBL] [Abstract][Full Text] [Related]
14. Measurement of the actual dose of triamcinolone acetonide delivered by common techniques of intravitreal injection. Ober MD; Barile GR; Tari SR; Tosi GM; Schiff WM; Chang S Am J Ophthalmol; 2006 Oct; 142(4):597-600. PubMed ID: 17011851 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Jonas JB Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide]. Jonas JB; Kreissig I; Degenring RF Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391 [TBL] [Abstract][Full Text] [Related]
17. Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema. Spandau UH; Derse M; Schmitz-Valckenberg P; Papoulis C; Jonas JB Br J Ophthalmol; 2005 Aug; 89(8):999-1003. PubMed ID: 16024853 [TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone acetonide concentration after subtenon injection. Thomas ER; Wang J; Ege E; Madsen R; Hainsworth DP Am J Ophthalmol; 2006 Nov; 142(5):860-1. PubMed ID: 17056371 [TBL] [Abstract][Full Text] [Related]
19. Carboxymethylcellulose as a new carrier substance for intravitreal injection of reproducible amounts of triamcinolone. Kube T; Sutter M; Trittler R; Feltgen N; Hansen LL; Agostini HT Graefes Arch Clin Exp Ophthalmol; 2006 Nov; 244(11):1385-90. PubMed ID: 16715253 [TBL] [Abstract][Full Text] [Related]
20. Further characterization of ocular safety profile of commercially available preserved and preservative-free triamcinolone acetonide. Li Y; Chen H; Hou J; Zhang Y; Li G; Gu X; Luo L; Shen H; Qu J; Cheng L Retina; 2012 Feb; 32(2):364-74. PubMed ID: 21909054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]